LFG
BIOC

Larson Financial Group’s Biocept, Inc. BIOC Stock Holding History

Larson Financial Group’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-33
Closed -$4K – 948
2020
Q4 		$4K Buy
+33
New +$4.7K ﹤0.01% 589

Other funds holding BIOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $87.6B AUM 131.08% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $463M AUM 16% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Larson Financial Group's BIOC Position: Q1 2021 in Review

Larson Financial Group sold out of Biocept, Inc. (BIOC) in Q1 2021, closing a stake of 33 shares — an estimated $4K sold.

Larson Financial Group first reported a position in BIOC in Q4 2020 and held it in 1 quarter. The position peaked at $4K in Q4 2020. 22 funds tracked by Wall St. Rank hold BIOC as of Q1 2021.

  • Larson Financial Group reported no remaining Biocept, Inc. position as of Q1 2021 after selling out during the quarter.
  • Larson Financial Group sold 33 Biocept, Inc. shares in Q1 2021, an estimated $4K.
  • Larson Financial Group first reported a position in Biocept, Inc. in Q4 2020 and held it in 1 quarter.
  • Larson Financial Group's Biocept, Inc. position peaked at $4K in Q4 2020.
  • 22 funds tracked by Wall St. Rank held Biocept, Inc. as of Q1 2021.

Based on Larson Financial Group's 13F filing for Q1 2021, filed 8 Apr 2021.